Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...

Former New York Giants quarterback Eli Manning is putting together an investment group to bid for a piece of the National ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp.

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

President Donald Trump’s tariffs have two primary objectives. One is to rebalance the world trade order, which he believes is ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

The company says it will submit orforglipron for weight management to regulators ... The Motley Fool Stock Advisor analyst ...

Steve brings deep experience in strategic transactions to Werewolf at this critical time,” said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. “Werewolf is ...

Teladoc stock has declined significantly, from a high of $14 per share in February to $7 per share. Read why I downgrade TDOC ...

Verticals from pharmaceuticals and food manufacturing to heavy industry uncover measurable improvements in asset reliability ...